| Literature DB >> 15123258 |
Emily L Humphrey1, Alykhan F Shamji, Bradley E Bernstein, Stuart L Schreiber.
Abstract
Treating yeast cells with rapamycin, a small molecule that inhibits the TOR proteins, leads to the repression of many genes. Consistent with prior studies, we find that RPD3, which encodes a histone deacetylase (HDAC), is required for repression upon rapamycin treatment. To elucidate the mechanism underlying RPD3-mediated repression, we screened all promoters in yeast for occupancy by Rpd3p before and after treatment with rapamycin. We find that Rpd3p binds to the promoters of rapamycin-repressible genes only following treatment. These data conflict with a previously proposed model suggesting that Rpd3p is constitutively bound to rapamycin-repressible genes and becomes active only after a stimulus such as treatment with rapamycin. Rather, the comprehensive analysis presented here strongly supports a model in which recruitment of Rpd3p to gene promoters is a regulated step in the control of gene repression.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15123258 DOI: 10.1016/j.chembiol.2004.03.001
Source DB: PubMed Journal: Chem Biol ISSN: 1074-5521